AGT and COVID-19: Considering these facts, the impairment of the protective ACE2 receptor pathway by SARS-COV-2 increases deleterious angiotensin II activity, leading to the induction of pro-inflammatory responses and an increase in blood pressure (Bornstein et al., 2020[4][5]), which result in a higher risk of adverse complications in patients with diabetes and COVID-19.